FINWIRES · TerminalLIVE
FINWIRES

Blue Moon在美国盘前交易中上涨4%,此前该公司公布了Nussir项目可行性研究结果。

-- 蓝月金属公司 (MOON.V) 在美国盘前交易中股价上涨 4%,此前该公司完成了挪威努西尔 (Nussir) 项目的可行性研究,该研究基于 8% 的折现率,估算出该项目税后净现值为 2.35 亿美元。 该公司在一份声明中表示,该估值基于长期铜价为每磅 4.78 美元、金价为每盎司 3,515 美元、银价为每盎司 45.26 美元。按市场普遍预期价格计算,该项目可开采金属的构成比例为:铜 77%、金 6%、银 13%。 蓝月金属公司还指出,该项目 13 年矿山寿命期内,按市场普遍预期价格计算的税后内部收益率为 19%,按现货价格计算则为 31%;初始资本支出为 1.84 亿美元。 该项目预计在 13 年矿山寿命期内每年可生产 19,000 吨铜当量。该项目拥有探明和指示资源量2872万吨,铜当量品位1.20%;探明和概略储量2498万吨,铜当量品位0.99%。 此外,该公司表示,已推进该项目的基础工程设计,并已订购选矿厂所需的长周期设备(半自磨机、球磨机和浓缩机)。该公司还为该项目购置了主电源变压器,以降低项目执行进度风险。截至目前,Blue Moon已在该项目上投入约4670万美元;截至2026年4月15日,斜坡道推进距离为1548米,预计将于2026年中期接近目标矿化体。 “由于该资产强劲的自由现金流以及迄今为止在Nussir项目上投入的股权,我们在剩余资本成本的融资渠道方面拥有很大的灵活性,”首席执行官Christian Kargl-Simard表示。 蓝月石油公司计划于2027年第三季度开始对该工艺装置进行热调试。 该公司股票昨日在加拿大小幅上涨。

Related Articles

Asia

Update: Origin Energy Reports Lower March Quarter Production; Shares Fall 3%

(Updates to add stock movement in the headline and last paragraph)Origin Energy (ASX:ORG) reported March quarter production of 164.5 petajoules, down from 167.1 petajoules a year earlier, according to a Monday filing with the Australian bourse.The company reported commodity revenue of AU$1.86 billion for the quarter, down from AU$ 2.31 billion a year ago, per the filing.Origin Energy also said its electricity sales volume increased 4% from a year earlier amid "strong growth" in business volumes driven largely by the data-center sector.The company's shares fell 3% in recent Monday trade.

$ASX:ORG
Asia

Alterity Therapeutics Secures US FDA Support for ATH434 Phase Three Program

Alterity Therapeutics (ASX:ATH) said it received positive feedback from a second type C meeting with the US Food and Drug Administration (FDA) on its planned phase three program for drug candidate ATH434, aimed at treating multiple system atrophy (MSA), according to a Monday filing with the Australian bourse.MSA is a progressive neurodegenerative disorder affecting autonomic and motor function with no approved disease-modifying therapies.The US FDA provided supportive written feedback on the program's chemistry, manufacturing, and controls, complementing earlier guidance from a separate type C meeting on clinical pharmacology and non-clinical development, the filing added.

$ASX:ATH
Asia

Xinyuan Property Management's CFO Resigns

Xinyuan Property Management Service's (HKG:1895) chief financial officer, Wang Yong, has resigned, effective April 26, according to a Monday Hong Kong bourse filing.Wang stepped down to devote more time to personal commitments, the company said.The company said the resignation will not affect its normal operations, with Wang's duties to be reallocated internally on an interim basis.Xinyuan Property Management added that it is seeking a suitable replacement for the chief financial officer role.

$HKG:1895
Blue Moon在美国盘前交易中上涨4%,此前该公司公布了Nussir项目可行性研究结果。 | FINWIRES